---
title: Clearsynth vs DSK InnoSciences Ltd
slug_a: clearsynth
slug_b: dskinnosciences
site: cdmo
review_signal_gate: closed
canonical_path: /compare/clearsynth/dskinnosciences
---

# Clearsynth vs DSK InnoSciences Ltd

Side-by-side profile data from each company listing on this directory.

## Clearsynth

- Profile: [/companies/clearsynth](/companies/clearsynth)

Clearsynth — Clearsynth delivers advanced deuterium science, isotopically labelled compounds, custom synthesis, and specialized CDMO services for small-molecule drug discovery and development. ISO 17025, ISO 17034, and ISO 9001:2015 certified with capabilities spanning reference standards, generic APIs, process development, and scale-up manufacturing.

Services: 5. Modalities: 1. Indications: 0. Locations: 3. Certifications: 4. The strongest documented coverage currently appears in services (5).

### Services

- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Process Development
- CMC Analytical Development
- Quality Control Testing

### Modalities

- Small Molecule

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Pilot (10 kg – 100 kg)
- DEA licensed

## DSK InnoSciences Ltd

- Profile: [/companies/dskinnosciences](/companies/dskinnosciences)

DSK InnoSciences Ltd — DSK InnoSciences is an established contract chemistry services company in Bangalore, India, offering synthesis, process development, and manufacturing of pharmaceuticals, specialty chemicals, and peptides from milligram to kilogram scale.

Services: 6. Modalities: 2. Indications: 0. Locations: 1. Certifications: 2. The strongest documented coverage currently appears in services (6).

### Services

- Analytical Method Development & Validation
- Small Molecule Development & Manufacturing
- API Synthesis & Manufacturing
- Peptide Manufacturing
- Process Development
- CMC Analytical Development

### Modalities

- Small Molecule
- Peptide

### Development capabilities

- Analytical method development

### Manufacturing capabilities

- Drug Substance (DS)
- Max chemical: Commercial (>100 kg / tonne)
- Cryogenic (−80 °C)